{"entity":{"id":"tiumbio","kind":"company","name":"TiumBio","aka":["TiumBio Co., Ltd."],"tldr":"TiumBio is a South Korea-based biotechnology company running 2 late-stage cancer trials of TU2218 in biliary tract cancer, head and neck squamous cell carcinoma and colorectal cancer.","summary":"TiumBio, based in Seongnam, South Korea, is a biotechnology company. TiumBio develops treatments for rare and intractable diseases, including immunotherapies and biologics for cancer, hemophilia and endometriosis. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing TU2218 in biliary tract cancer, head and neck squamous cell carcinoma and colorectal cancer. The largest, NCT05204862 (Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumours), plans to enrol 240 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.tiumbio.com"},{"label":"ClinicalTrials.gov: trials led by TiumBio","url":"https://clinicaltrials.gov/search?lead=TiumBio%20Co.%2C%20Ltd."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["cholangiocarcinoma","head-and-neck","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05784688","nct05204862"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Seongnam","country":"KR","companyType":"biotech","website":"https://www.tiumbio.com","stage":"public","investors":[],"funding":[]},"route":"/companies/tiumbio/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"}],"trial":[{"id":"nct05204862","kind":"trial","name":"Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors","route":"/trials/nct05204862/"},{"id":"nct05784688","kind":"trial","name":"Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors","route":"/trials/nct05784688/"}]}}